BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18324879)

  • 1. The safety of diclofenac for the management and treatment of actinic keratoses.
    Iraji F; Siadat AH; Asilian A; Enshaieh S; Shahmoradi Z
    Expert Opin Drug Saf; 2008 Mar; 7(2):167-72. PubMed ID: 18324879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessment of topical diclofenac/hyaluronan gel for actinic keratoses.
    Burkhart CN; Burkhart CG
    Int J Dermatol; 2002 Jun; 41(6):371-2. PubMed ID: 12100697
    [No Abstract]   [Full Text] [Related]  

  • 3. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
    Rivers JK; McLean DI
    Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses.
    Rivers JK
    Skin Therapy Lett; 2004 Jan; 9(1):1-3. PubMed ID: 14716439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and emerging topical approaches for actinic keratoses.
    Del Rosso JQ
    Cutis; 2003 Oct; 72(4):273-6, 279. PubMed ID: 14604078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):373-9. PubMed ID: 12769404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical diclofenac in the treatment of actinic keratoses.
    Merk HF
    Int J Dermatol; 2007 Jan; 46(1):12-8. PubMed ID: 17214714
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical therapy for actinic keratoses: current and evolving therapies.
    Weinberg JM
    Rev Recent Clin Trials; 2006 Jan; 1(1):53-60. PubMed ID: 18393780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical 3.0% diclofenac in 2.5% hyaluronic acid gel induces regression of cancerous transformation in actinic keratoses.
    Dirschka T; Bierhoff E; Pflugfelder A; Garbe C
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):258-63. PubMed ID: 19709346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
    Berlin JM; Rigel DS
    J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.
    Rivers JK; Arlette J; Shear N; Guenther L; Carey W; Poulin Y
    Br J Dermatol; 2002 Jan; 146(1):94-100. PubMed ID: 11841372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
    Nelson C; Rigel D; Smith S; Swanson N; Wolf J
    J Drugs Dermatol; 2004; 3(4):401-7. PubMed ID: 15303784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment of actinic keratosis with 3.0% diclofenac in 2.5% hyaluronan gel: review of the literature about the cumulative evidence of its efficacy and safety.
    Javor S; Cozzani E; Parodi A
    G Ital Dermatol Venereol; 2016 Jun; 151(3):275-80. PubMed ID: 26512929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
    Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
    J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical and light-based treatments for actinic keratoses.
    Silapunt S; Goldberg LH; Alam M
    Semin Cutan Med Surg; 2003 Sep; 22(3):162-70. PubMed ID: 14649583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diclofenac for actinic keratoses: a formulation issue.
    Cox NH
    Clin Exp Dermatol; 2006 Nov; 31(6):819-20. PubMed ID: 16939582
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
    Ulrich C; Hackethal M; Ulrich M; Howorka A; Forschner T; Sterry W; Stockfleth E
    Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoallergic contact dermatitis from topical diclofenac in Solaraze gel.
    Kowalzick L; Ziegler H
    Contact Dermatitis; 2006 Jun; 54(6):348-9. PubMed ID: 16787462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.